Tuesday, May 2, 2017

Teewinot Life Sciences Corporation, a Global Leader in Pharmaceutical #Cannabinoid Production, Secures $12.3 Million Series B Round
Furthers Mission to Address Unmet Medical Needs Across the Globe

NEW YORK and TAMPA, Fla. - May 2, 2017 (Investorideas.com Newswire) Teewinot Life Sciences Corporation (Teewinot), an industry leader in discovery, development and commercialization of cannabinoid-based therapeutics and the global leader in the biocatalytic production of cannabinoids, announced today that it has closed it's $12.3 million Series B round led by Tuatara Capital, a New York based private equity fund focused on investments in cannabis-related companies. With the original Series B target having been set at $10 million, the funds raised were nearly 25 percent oversubscribed. Tuatara Capital also led Teewinot's $7 million Series A round in December 2015.
Read this news in full at http://www.investorideas.com/news/2017/marijuana/05022Teewinot.asp 
Marijuana / Hemp Stocks
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory
Global Cannabis Investing - features Investor Ideas Cannabis news

Watch the 420 Cannabis Investor video

More Info:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

No comments:

Post a Comment